Jianguo Sun

7PUBLICATIONS
7CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 24, 2026
Tumor-Derived Exosomes Deliver Membrane-Bound Fgl2 to Activate FcγRIIB-Mediated Immunosuppression in Myeloid-Derived Suppressor Cells.

Fenglin Lin, Dingqin Cai, Chunli Jian

|Jan 03, 2024
Population-based high-dimensional analyses identify multiple intrinsic characters for cancer vaccines against lung squamous cell carcinoma.

Longjin Zeng, Lingchen Li, Xingyun Liao

|Jun 30, 2023
YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer.

Ling-Chen Li, Xie-Wan Chen, Ling Fang

|Jan 06, 2022
Efficacy and safety of recombinant human endostatin during peri-radiotherapy period in advanced non-small-cell lung cancer.

Jianbo Zhu, Guangpeng Chen, Kai Niu

|Aug 06, 2021
Clinical features and death risk factors in COVID-19 patients with cancer: a retrospective study.

Yi Zhou, Qiao Yang, Jun Ye

|Jul 09, 2021
Fingerprint loss during combination therapy using osimertinib and anlotinib: A case report.

Lijiao Xie, Yongdong Feng, Jianguo Sun

Pageof 2